Non-Government Partner
Mylan
Previous
Namibia
Next
Myanmar
Mylan Laboratories is a leading global pharmaceutical company that operates in the generic and specialty pharmaceutical sector.
With a strong commitment to improving healthcare, Mylan focuses on providing affordable access to high-quality medicines. Their broad portfolio includes a range of pharmaceutical products, including oral contraceptive pills, injectables, and various other medications.
Commitments made to:
Vision
As a supplier of oral contraceptive pills, injectables, and a growing number of other methods, Mylan committed to offering contraceptives to 25 million women and girls by 2020 in 2017. Mylan will also work to expand its contraceptive portfolio to 80 percent of the 69 FP2020 countries, to ensure equitable access to women and girls across the globe.
Mylan Commitment Narratives
- Strive to offer contraceptives to 25 million women and girls by 2020, including oral contraceptive pills, injectables, and other methods.
- Aim to register their contraceptive portfolio in 80% of the 69 FP2020 countries, ensuring equitable access to women and girls worldwide.
- Continuously strengthen and expand manufacturing capacities to meet the growing demand for contraceptives, particularly WHO PQ oral contraceptives.
Become an FP2030 Partner
